Miguel Ángel Treviño Morales and Omar Treviño Morales, leaders of the criminal organization Los Zetas, pleaded not guilty in a Washington, D.C., federal court.
The proceedings mark a critical step in the prosecution of two of the most influential figures in the Mexican drug trade. The case underscores the U.S. government's ongoing effort to dismantle high-level cartel leadership through the American judicial system.
Appearing before the U.S. District Court for the District of Columbia, the brothers—known by the aliases Z-40 and Z-42—faced charges related to drug trafficking and associated offenses [1]. During the hearing, the defense sought relief from solitary confinement for the brothers, but the judge said the motion was rejected [1], [2].
A significant procedural conflict emerged regarding the volume of evidence. The prosecution presented an evidentiary schedule consisting of five million pieces of evidence [3]. The defense rejected this schedule, saying that the scale of the discovery process would impact the timeline of the proceedings [3].
Because of these disputes, the court has not yet finalized a trial date. Prosecutors said that the trial should begin in January 2028 [3]. The judge instead scheduled a new hearing for September to establish a definitive trial date [3].
The Treviño Morales brothers have long been identified as key architects of the Los Zetas organization, which transitioned from a mercenary wing of the Gulf Cartel into a standalone criminal empire. Their presence in a U.S. court is part of a broader strategy to utilize federal drug-trafficking laws to secure long-term incarcerations for cartel heads [1], [2].
“The prosecution presented an evidentiary schedule consisting of five million pieces of evidence.”
The massive volume of evidence and the proposed 2028 trial date suggest a prosecution of unprecedented complexity. By maintaining solitary confinement and pushing for a comprehensive evidentiary record, the U.S. government is attempting to ensure a conviction that withstands appeals, while the defense is leveraging the sheer scale of the data to delay the trial.
